The most potent antigen-presenting cells, DCs, are capable of highly effective presentation of antigens to naïve T cells and able to initiate primary immune responses. DCs are the cells most ...

Transfecting LCMV-GP into a fibrosarcoma line as a surrogate tumor antigen, dendritic-cell vaccination against GP led to an anti-tumor immune response as well as diabetes in RIP-GP mice as ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...